Company intelligence / Profile preview

DermOQ

Ownership: Private
Development stage: Other

Overview

DermOQ commercializes oxygen-based facial treatments (ECHO2 Plus) offered in physician offices, spas, hotels, and corporate retail settings, and sells complementary topical oxygen skincare products (OQ Oxygen Lab line) such as 'Cell Fuel' aimed at enhancing and extending the effects of professional oxygen facials.[1][6]

Therapeutic areas: Dermatology
Modalities: Non-pharmacological therapyDeviceTopical cosmetic product
Industry: Therapeutic Medical Devices

Partnerships

Acquired ECHO2 Plus oxygen facial treatment product line from Skin Products (transactional relationship rather than ongoing strategic partnership).[1][6]

Beyond the preview

Go deeper on DermOQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermOQ.

Explore the full profile